Eli Lilly (LLY) Buildings (2012 - 2024)

Eli Lilly has reported Buildings for 13 years, with the latest figure at $8.8 billion in Q4 2024.

• For the quarter ending Q4 2024, Buildings rose 6.36% year-over-year to $8.8 billion; the trailing twelve-month figure through Dec 2024 stood at $8.8 billion (up 6.36% YoY), and the FY2024 full-year result was $8.8 billion, up 6.36% from the prior year.
• Buildings for Q4 2024 stood at $8.8 billion, up from $8.3 billion in the prior quarter.
• The five-year high for Buildings was $8.8 billion in Q4 2024, with the low at $7.3 billion in Q4 2020.
• Historically, Buildings has averaged $8.0 billion across 5 years, with a median of $7.9 billion in 2022.
• Annual changes were most pronounced in 2021 — Buildings advanced 3.58% — and 2024, when it increased 6.36%.
• Eli Lilly's Buildings stood at $7.3 billion in 2020, then rose by 3.58% to $7.6 billion in 2021, then rose by 4.32% to $7.9 billion in 2022, then grew by 4.6% to $8.3 billion in 2023, then increased by 6.36% to $8.8 billion in 2024.
• The last three Buildings figures came in at $8.8 billion (Q4 2024), $8.3 billion (Q4 2023), and $7.9 billion (Q4 2022), per Business Quant data.